Author | Year | Country | N (OG/CG) | Adiponectin Source | Assay approach | NOS |
---|---|---|---|---|---|---|
Huang et al. [26] | 2004 | China | 84 (69/15) | Serum | RIA | 6 |
Zhang et al. [8] | 2005 | China | 86 (66/20) | Serum | RIA | 6 |
Wolk et al. [11] | 2005 | USA | 55 (26/29) | Plasma | RIA | 7 |
Sharma et al. [15] | 2007 | India | 80 (40/40) | Plasma | ELISA | 7 |
Ursavas et al. [12] | 2010 | Turkey | 70 (55/15) | Serum | RIA | 8 |
Ebru et al. [16] | 2011 | Turkey | 50 (26/24) | Serum | RIA | 7 |
Öztürk et al. [18] | 2012 | Turkey | 94 (62/32) | Serum | ELISA | 6 |
Sánchez et al. [17] | 2012 | Spain | 41 (21/20) | Plasma | RIA | 7 |
Kritikou et al. [19] | 2013 | USA | 67 (36/31) | Serum | ELISA | 7 |
Hargens et al. [10] | 2013 | USA | 30 (12/18) | Serum | ELISA | 8 |
Mutairi et al. [20] | 2014 | Kuwait | 147 (105/42) | Plasma | ELISA | 7 |
Xu et al. [28] | 2014 | China | 82 (62/20) | Serum | ELISA | 7 |
Wen et al. [27] | 2015 | China | 48 (33/15) | Serum | ELISA | 7 |
Kim et al. [22] | 2015 | Korea | 59 (37/22) | Plasma | RIA | 7 |
Araújo et al. [21] | 2015 | Brazil | 53 (33/20) | Plasma | ELISA | 7 |
Zuo et al. [29] | 2016 | China | 89 (59/30) | Serum | ELISA | 6 |
Lacedonia et al. [23] | 2016 | Italy | 20 (10/10) | Serum | ELISA | 7 |
Yang et al. [30] | 2017 | China | 73 (35/38) | Serum | ELISA | 7 |
Abdel et al. [24] | 2017 | Egypt | 44 (22/22) | Serum | ELISA | 7 |
Chen et al. [25] | 2017 | China | 84 (69/15) | Serum | ELISA | 8 |